Axington given more time to release FY2020 results and hold AGM
CATALIST-LISTED Axington Inc, which was embroiled in the Bellagraph Nova saga, has gained a one-month extension from the Singapore Exchange to issue its FY2020 results by March 31.
It has also been granted a 2.5 months extension, to July 22, to hold its FY2020 annual general meeting, it announced in a Wednesday bourse filing after the market close. It will also have another 2.5 months, to June 30, to file its sustainability report.
The basis for the extensions is the series of events following the Bellagraph Nova saga. In July 2020, Axington had undergone a change of management after a mandatory unconditional cash offer from Dorr Global Healthcare International, a firm linked to the cousins Terence and Nelson Loh of Bellagraph Nova Group.
But controversy erupted over Bellagraph Nova after it came to light that it had doctored photographs showing former US President Barack Obama in marketing materials, as well as made unverified claims about the scale of its business.
Axington subsequently announced the resignations of a majority of its board members in August 2020, including that of its sole executive director, Marjory Loh, the sister of Terence Loh.
Axington's board and board committees, including the audit, remuneration and nominating committees, were reconstituted only in November 2020, the firm noted in its filing.
GET BT IN YOUR INBOX DAILY
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
It will next submit an application to the Labuan Financial Services Authority for an extension of time to hold its FY2020 AGM. Shares of the firm last traded at S$0.19 before suspension.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
DBS customers unable to log into digibank, PayLah! on Thursday
US: Wall St opens higher after Fed leaves interest rates alone
Japan’s Sumitomo Corp net profit down 32% on Madagascar one-off loss
Moody's tops quarterly profit estimates on strong product demand
Hong Kong regulator brings insider trading charges against Segantii and its founder
Novartis to buy radiology specialist Mariana Oncology for US$1 billion